Charlotte L. Deijen1, Gerbert L. Vrijenhoek1, Eva E. Schaake1, Wouter V. Vogel1,2, Luc M.F. Moonen1, Floris J. Pos1, Henk G. van der Poel3, Gerben R. Borst1
1Department of Radiation Oncology, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands
2Department of Nuclear Medicine, Antoni van Leeuwenhoek The Netherlands Cancer Institute, Amsterdam, the Netherlands
3Department of Urology, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands